Related Experiment Video
Updated: Jun 4, 2026

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors
Florence Brellier1, Sabrina Ruggiero, Daniela Zwolanek
1Friedrich Miescher Institute for Biomedical Research, Novartis Research Foundation, Basel, Switzerland. florence.brellier@fmi.ch
Abstract:
Tenascin-C is an extracellular matrix protein over-expressed in a large variety of cancers. In the present study, we aimed at identifying new interactors of tenascin-C by purifying secreted proteins on a tenascin-C affinity column. Analysis of eluates by mass spectrometry revealed phosphoglycerate kinase 1, clusterin, fibronectin, SPARC-related modular calcium-binding protein 1 (SMOC1) and nidogen-2 as potential interactors of tenascin-C. The interaction between tenascin-C and SMOC1 was confirmed by co-immunoprecipitation and further analyzed by Surface Plasmon Resonance Spectroscopy, which revealed an apparent dissociation constant (K(D)) value of 2.59∗10(-9)M. Further analyses showed that this binding is reduced in the presence of EDTA. To investigate whether SMOC1 itself could be over-expressed in the context of tumorigenesis, we analyzed data of two independent RNA profiling studies and found that mRNA levels of SMOC1 are significantly increased in oligodendrogliomas compared to control brain samples. In support of these data, western blot analysis of protein extracts from 12 oligodendrogliomas, 4 astrocytomas and 13 glioblastomas revealed elevated levels compared to healthy brain extract. Interestingly, cell migration experiments revealed that SMOC1 can counteract the chemo-attractive effect of tenascin-C on U87 glioma cells. The present study thus identified SMOC1 as a new cancer-associated protein capable of interacting with tenascin-C in vitro.
Insights
Researchers identified SPARC-related modular calcium-binding protein 1 (SMOC1) as a novel interactor of tenascin-C, a protein overexpressed in many cancers. SMOC1 is also elevated in brain tumors and can modulate tenascin-C
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Tenascin-C is an extracellular matrix protein frequently overexpressed in various cancers.
- Identifying tenascin-C interactors can reveal new insights into cancer biology and potential therapeutic targets.
Purpose of the Study:
- To identify novel proteins that interact with tenascin-C.
- To investigate the role of SPARC-related modular calcium-binding protein 1 (SMOC1) in cancer, particularly its interaction with tenascin-C and its expression levels in brain tumors.
Main Methods:
- Affinity purification of secreted proteins using a tenascin-C column followed by mass spectrometry.
- Co-immunoprecipitation and Surface Plasmon Resonance Spectroscopy to confirm and quantify tenascin-C and SMOC1 interaction.
- Analysis of RNA profiling data and Western blot to assess SMOC1 expression in brain tumors.
- Cell migration assays to evaluate the functional impact of SMOC1 on tenascin-C-mediated glioma cell behavior.
Main Results:
- Mass spectrometry identified phosphoglycerate kinase 1, clusterin, fibronectin, SMOC1, and nidogen-2 as potential tenascin-C interactors.
- The interaction between tenascin-C and SMOC1 was confirmed, with a K(D) of 2.59∗10(-9)M, sensitive to EDTA.
- SMOC1 mRNA and protein levels were significantly increased in oligodendrogliomas, astrocytomas, and glioblastomas compared to normal brain tissue.
- SMOC1 demonstrated the ability to counteract the chemo-attractive effect of tenascin-C on U87 glioma cells.
Conclusions:
- SPARC-related modular calcium-binding protein 1 (SMOC1) is a novel cancer-associated protein that interacts with tenascin-C.
- SMOC1 expression is elevated in brain tumors, suggesting a role in tumorigenesis.
- SMOC1 may play a role in modulating cancer cell migration in response to tenascin-C.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cytoskeletal Accessory Proteins
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...